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ABSTRACT
Introduction: Morinda citrifolia or also known as noni is commonly consumed raw or blanched as side dishes or 
‘ulam’. As cancer is one of the most leading causes of death in the world, we aimed to evaluate the anti-prolifera-
tive potential of noni shoot against various types of cancer cell lines. Methods: The breast cancer (MDA-MB-231), 
liver cancer (HepG2), and colorectal cancer (HT-29) cell lines were treated with 70% ethanol extract of noni shoot 
for cytotoxicity testing using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis 
induction effects were examined using AO/PI dual fluorescent assay and cell cycle analysis using flow cytometry. 
Gas chromatography-mass spectrometry (GCMS) was also carried out to characterize the active compounds in noni 
shoot. Results: The cytotoxicity assay demonstrated noni shoot had IC
50
 of 49.72 µg/mL, 307.5 µg/mL and 65.43 µg/
mL against MDA-MB-231, HepG2, and HT-29 cell lines, respectively. The AO/PI staining showed apoptotic bodies 
such as cell blebbing, chromatin condensation, and nuclear fragmentation was markedly induced in the selected 
cancer cell lines-treated with noni shoot extract.  Apoptosis induction by noni shoot was showed by a significant 
increase in sub G
0
/G
1
 phase in MDA-MB-231 and HT-29 cell lines of cell cycle analysis. It was found that noni shoot 
extract contained mostly acetic acid and ethriol that may contribute to its anti-cancer properties. Conclusion: These 
findings showed the potential anticancer properties of noni shoot extract thereby, further studies are needed to un-
derstand the mechanism of noni as anti-cancer agent and possibility to be developed as a nutraceutical or functional 
food products. 
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INTRODUCTION
Cancer is a leading cause of death in both more and 
less developed countries (1). Cancer can be defined 
as a disease where abnormal cells continue to grow 
in an uncontrolled manner and disregard the normal 
rules of cell division thus leading to activation of 
numerous gene that involved in survival, cell cycle, 
metastasis, and angiogenesis (2). From 2007 to 2011, 
it is reported that there are 103507 new cancer cases 
was diagnosed in Malaysia (3). From the number of 
new cases, 45.2 % (46794) cases were male patients 
and 54.8 % (56713) are females. Breast cancer, liver 
cancer, and colorectal cancer are most common cancer 
worldwide and all three types of cancer placed in top 
five in both men and women worldwide and global 
incidence were remarkably rising (4). There are many 
types of cancer treatment that provided to the patients 
that include surgery, radiotherapy, and applications of 
chemotherapy drugs, the biological molecule as well 
as immune-mediated therapies (5). Recently, many 
research has targeted the stimulation of programmed 
cell death also known as apoptosis as a prime molecular 
target for chemoprevention and treatment of cancer 
(6). Using plant-derived compounds or phytochemicals 
therapeutics approach for cancer have been applied 
extensively and natural compounds that isolated from 
medicinal plants are the lead compounds as the anti-
cancer agents (7). 
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Morinda citrifolia L. or noni is originated in Southeast 
Asia and the plant has been brought to another tropic 
region such as Australia, Asia Pacific and Caribbean 
(8). Noni was claimed to possess medicinal properties 
by old folks throughout generations although there 
is no or little scientific evidence to prove the claims 
(9). Noni leaves are used to treat bacterial infections, 
inflammation, hemorrhage, burns wounds, fever (10), 
rheumatic aches and swelling of joints (11). In addition, 
noni leaves are rich in carotenoids which is important 
to treat vitamin A deficiency (12). Thani et al. (2010) 
have also shown that noni extract exhibited anti-cancer 
properties against human epidermoid carcinoma (KB) 
and human cervical carcinoma (HeLa) cells (13). Aside 
from leaves, it is also reported that other parts of the 
noni also possess health benefits. Noni fruit juice is used 
in alternative medicine for the treatment of diabetes, 
arthritis, digestion problems, atherosclerosis and many 
more (14). Furthermore, noni fruits may suppress tumour 
growth through activation of the immune system in 
Lewis lung (LLC) peritoneal carcinomatosis model (15), 
neuroblastoma (36 %) and breast cancer (29 %) (16). 
Nowadays, most of the pharmaceutical agencies were 
mostly relies on natural products that originated from 
traditional medicinal plants and always exploring for 
possible traditional plants that might have medicinal 
properties. The current study demonstrates the potential 
anti-proliferative effects of Morinda citrifolia shoot 
extract towards breast cancer (MDA-MB-231), liver 
cancer (HepG2), and colorectal cancer (HT-29) cell 
lines.
 
MATERIALS AND METHODS
Materials and chemicals
Ethanol was bought from Fisher Scientific 
(Loughborough, Leicestershire, UK). MTT, dimethyl 
sulfoxide (DMSO), phosphate-buffered saline (PBS), 
and doxorubicin were purchased from Sigma (St. Louis, 
MO, USA). BD CycletestTM Plus DNA was obtained from 
BD Biosciences Pharmingen (Franklin Lakes, NJ, USA). 
Roswell Park Memorial Institute (RPMI)-1640 medium 
were purchased from Nacalai Tesque Co. (Kyoto, Japan). 
Penicillin and streptomycin (100 x), fetal bovine serum 
(FBS), and trypsin-EDTA (1 x) were purchased from PAA 
Laboratories GmBH (Pasching, Austria).
Sample preparation
Fresh noni shoot was obtained from University 
Agriculture Park, Universiti Putra Malaysia (UPM) and 
identified by Dr. Mohd Firdaus Ismail from Biodiversity 
Unit, Institute of Bioscience, UPM, Selangor, Malaysia 
(Voucher no: SK 3217/17). The noni shoots were 
washed and lyophilized for 48 h. The samples were 
extracted using 70 % ethanol  (17, 18). Briefly, 2g of 
the freeze-dried sample was mixed with 100 milliliters 
(100 ml) of 70 % ethanol. The mixture then centrifuged 
at 1536 x g for 5 minutes. The supernatant was removed 
using a rotary evaporator and the extract was reserved 
for analysis. 
Cell culture
Human breast cancer (MDA-MB-231), hepatocellular 
cancer (HepG2), colorectal cancer (HT-29), and mouse 
fibroblast (BALB/c 3T3) cell lines were grown in RPMI 
supplemented with 10 % (v/v) fetal bovine serum (FBS), 
100 IU/ml penicillin, and 100 µg/ml streptomycin. 
MTT cytotoxic assay
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo- 
lium bromide) assay was used to examine cell 
proliferation (19). Briefly, noni shoot extract was 
incubated in the selected cell lines for 72 hours with 
various concentrations of the extract and the absorbance 
was read at 570 nm. The endpoint criteria for anti-
proliferative activity was selected according to the 
cytotoxic activity of IC
50
 values that below 100 µg/ml for 
crude extracts (20). Therefore, for further analysis, only 
selected cancer cells with low IC
50
 values (< 100 µg/mL) 
which showed promising and greater anti-proliferative 
effects were chosen.
Acridine orange/Propidium iodide (AO/PI) dual 
fluorescent assay
The selected cancer cell lines were treated with IC
50
 
concentrations obtained from the MTT assay and 
incubated for 24, 48, and 72 hours. Cells were stained 
with 1 mg/ml of acridine orange (AO) and propidium 
iodide (PI) and observed using a fluorescence microscope 
(21). 
Cell cycle 
BD CycletestTM Plus DNA reagent kit was used to 
determine cell cycle distribution (BD Biosciences, San 
Jose, CA, USA). The MDA-MB-231 cells were incubated 
with 25 µg/mL, 50 µg/mL, and 75 µg/mL of noni shoot 
extract for 72 hours of incubation. The HT-29 cell lines 
were incubated with 33 µg/mL, 65 µg/mL and 98 µg/
mL of sample extracts for 72 hours. Data were analysed 
using the FACS Calibur flow cytometer with Cell Quest 
3.3 software (22).
Gas Chromatography-Mass Spectrophotometry 
(GCMS) 
GCMS analysis was carried out on Shimadzu GCMS 
QP2010 Plus  (Kyoto, Japan) equipped with  SGE BPX5 
column (30 m length x 0.25 mm I.D x 0.25 µm film 
thickness) (23). Oven temperature was set at initial 
temperature of 50 °C /1 minute and increased to 240 
°C with 5 °C/1 minute increment followed by a ramp of 
10 °C/1 minute to 280°C/15 min. The inlet temperature 
was 250 °C and the transfer line temperature was 280 
°C. The mobile phase was using helium as a carrier gas 
and set a flow rate of 1.0 ml/1 minute. The spectral data 
were compared with the National Institute Standard and 
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Technology (NIST) NIST08 GCMS library database.
Data analysis 
Data were expressed as the mean ± standard deviation 
(SD) and analyzed using one-way analysis of variance 
(ANOVA) with Tukey’s multiple range test. A p-value of 
<0.05 was considered significant. 
RESULTS
Cytotoxic effects 
The MDA-MB-231, HepG2, HT-29 and BALB/c 
3T3 cell lines were initially incubated with various 
concentrations of the extract (0 - 1000 µg/mL) for 72 
hours. Table I shows the IC
50
 values of noni extract in 
MDA-MB-231, HepG2, HT-29, and 3T3 cell lines. Noni 
shoot extract had demonstrated the lowest IC
50
 value 
in MDA-MB-231 (49.72 µg/mL), followed by HT-29 
(65.43 µg/mL) and HepG2 (307.5 µg/mL), indicating it’s 
marked and highly cytotoxic effects on breast cancer 
and colorectal cancer cell lines and less cytotoxic 
in liver cancer cell lines. The lower the IC
50
 value of 
extract showing the higher cytotoxicity effects, thereby 
has potential as anti-proliferative agents. In addition, the 
results showed that no cytotoxic effect was observed on 
BALB/c 3T3 cell lines after incubated with noni shoot 
extract for 72 hours (IC
50
 cannot be determined; >80% 
of cells growth). These findings showed that the noni 
shoot extract is selective anti-cancer agents because it 
only caused the cell death in cancer cell lines without 
affecting the normal cell. 
Doxorubicin that was used as positive control in this 
study, is one of the chemotherapy drugs capable to 
induce toxicity in MDA-MB-231, HepG2, and HT-
29 cell lines (IC
50
 value of 1.87, 2.29, and 1.93 µg/ml 
respectively; Table I). Nonetheless, doxorubicin also 
showed a high cytotoxic effect in BALB/c 3T3 normal 
mouse fibroblast cells. 
Acridine orange and propidium iodide double staining 
The MDA-MB-231 cell lines were incubated with noni 
shoot extract (50 µg/mL) for 24, 48 and 72 hours of 
incubations. The MDA-MB-231 cell lines-incubated 
Figure 1: Morphological characterization of breast cancer (MDA-
MB-231) cell lines after incubation with noni shoot extract using acri-
dine orange (AO) and propidium iodide (PI) staining. Breast cancer, 
MDA-MB-231 cell lines were either (A) untreated (VC: viable cell) or 
treated with noni shoot extract (49.72 µg/ml) after 24 h (B), 48 h (C) 
and 72 h (D) of incubations. Incubation of MDA-MB-231 cell lines 
with noni shoot extract showed the characteristics of apoptosis such as 
chromatin condensation (CC), nuclear fragmentation (NF), cell bleb-
bing (CB) and late apoptosis (LA) (Magnification 400 x).
with noni shoot extract had demonstrated the early 
apoptosis features such as cell blebbing and chromatin 
condensation (Fig. 1B) after 24 hours of incubation. The 
MDA-MB-231 cell lines showed both early apoptosis 
and late apoptotic cells which indicated by orange 
colour emission after 48 hours (Fig. 1C). After 72 hours, 
there were signs of late apoptotic cells and secondary 
necrosis cells in MDA-MB-231 cells (Fig. 1D). 
Table I: IC
50
 values of noni shoot extract and doxoru-
bicin in breast cancer (MDA-MB-231), liver cancer 
(HepG2), colorectal cancer (HT-29), and normal mouse 
fibroblast (BALB/c 3T3) cell lines
Cell lines 
IC
50
 value (µg/mL)
Noni shoot extract Doxorubicin
 MDA-MB-231 49.72 1.87
 HepG2 307.50 2.29
 HT-29 65.43 1.93
 BALB/c 3T3 N/A 1.96
N/A= IC
50
 cannot be determined
The HT-29 cell lines were incubated with noni shoot 
extract (65 µg/mL) for 24, 48 and 72 hours of incubations. 
As shown in Fig. 2, the HT-29 cell lines exhibited early 
apoptotic features i.e. chromatin condensation and cell 
blebbing after 24 hours of incubation with noni extract 
(Fig. 2B). When compared to control (untreated cells), 
the cells were appeared to be healthy as they exhibited 
green colour (Fig. 2A). The late apoptosis (orange colour) 
were also detected only after 24 hours (Fig. 2B). In 
addition, the cells that exhibited early and late apoptotic 
features were increased after 48 hours (Fig. 2C). After 72 
hours, cells with secondary necrosis were observed in 
addition to early and late apoptotic cells (Fig. 2D). 
Cell cycle analysis 
The MDA-MB-231 cell lines were incubated with noni 
shoot extract (25, 50, 75 µg/mL) for 72 hours. As shown 
in Fig. 3, there was an increment of the cell population 
in Sub-G
0
/G
1
 phase following the incubation with noni 
shoot extract when compared with control. In addition, 
the proportion of cells in G
0
/G
1
 phase was decreased 
following the increment of concentrations of noni shoot 
extract. The cell population of the control (untreated 
cells) were as followed; sub G
0
/G
1
 (6.71 + 4.45 %), G
0
/
G
1
 (67.36 + 6.21 %), S (9.42 ± 3.24 %), and M (14.15 
± 8.25 %). After 72 h, there was significant increased 
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(p<0.05) in the proportion of cells in the S phase of the 
cell cycle for HT-29 cell lines-treated with noni shoot 
extract (33 and 65 µg/ml), as shown in Fig. 4.
Gas Chromatography-Mass Spectrophotometry 
(GCMS) analysis of noni shoot extract
The result of the GCMS analysis of an ethanolic extract 
of noni shoot extract was shown in Table II. The most 
abundant compounds in noni shoot extract are acetic 
acid (17.98 %) and ethriol (16.59 %).
Figure 2: Morphological characterization of colorectal cancer (HT-
29) cell lines after incubation with noni shoot extract using acridine 
orange (AO) and propidium iodide (PI) staining. Colorectal cancer, 
HT-29 cell lines were either (A) untreated (VC: viable cell) or treated 
with noni shoot extract (65.43 µg/ml) after 24 h (B), 48 h (C) and 72 h 
(D) of incubations. Incubation of HT-29 cells with noni shoot extract 
showed the characteristics of apoptosis such as chromatin conden-
sation (CC), nuclear fragmentation (NF), cell blebbing (CB) and late 
apoptosis (LA) (Magnification 400 x).
Figure 3: Cell cycle distributions in MDA-MB-231 cell lines after in-
cubation with three different concentrations (25, 50, and 75 µg/mL) 
of noni shoot extract for 72h. The cell cycle kinetics were analysed 
using flow cytometry. Values are reported as mean ± SD (n=3) and 
different letters are significant relative to respective control by Tukey’s 
test at p<0.05.
(p<0.05) of the cell proportion in the sub G
0
/G
1
 for the 
treated-cells with noni shoot extract (25, 50, 75 µg/
mL) when compared to the control in dose-dependent 
manner (27.47 ± 4.23 %, 43.26 ± 5.24 %, and 85.22 
± 4.89 %, respectively). Besides, the proportion of cells 
in other phases (G
0
/G
1
, S, and G
2
/M) were significantly 
decreased (p<0.05) in a dose-dependent manner (Fig. 
3).
As shown in Fig. 4, there were increased in the cell 
population of the sub G
0
/G
1
 phase of HT-29 following 
treatment with noni extracts. The proportion of cells in 
sub G
0
/G
1
 phase was significantly increased (p<0.05) in 
HT-29-treated with noni shoot extract (33, 65, 98 µg/ml; 
26.32 ± 4.17 %, 55.14 ± 5.45 %, and 83.42 ± 7.45 % 
respectively) when compared to the control (only 4.21 
± 1.42 %). In addition, there was a significant increase 
Figure 4: Cell cycle distributions in HT-29 cell lines after incubation 
with three different concentrations (33, 65, and 98 µg/mL) of noni 
shoot extract for 72h. The cell cycle kinetics were analysed using 
flow cytometry. Values are reported as mean ± SD (n=3) and different 
letters are significant relative to respective control by Tukey’s test at 
p<0.05.
Table II: Compounds that identified in noni shoot extract using GCMS
Peak Compound Retention Time Area (%)
1 1H-Pyrrole 3.21 0.24
2 Toluene 3.63 0.01
3 Propenoic acid 3.97 0.24
4 Acetic acid 4.31 0.30
5 Glycerin 4.63 0.81
6 2-Hexanone 5.47 0.08
7 Propanal 5.8 0.28
8 m-xylene 6.04 0.01
9 Glyceraldehyde 6.19 0.17
10 3-Furanmethanol 7.05 0.18
11 Butanoic acid 7.53 0.56
12 Ethanimidic acid 7.92 0.18
13 Butyrolactone 8.11 0.26
14 Piperidine, Glutamic acid 9.75 1.91
15 Phosphonic acid 10.35 0.02
16 Carbolic acid 10.54 0.40
17 Sorbitol 10.76 0.11
18 Octadecanoic acid 11.91 0.14
19 Hyacinthin 12.08 0.03
20 Tetradecanoic acid 12.29 0.09
21 Allenton 13.36 0.46
22 Cyclopropyl carbinol 13.68 0.56
23 Valeric acid aldehyde 14.82 0.32
24 Acetoacetic acid 14.87 4.01
25 Glycerin 15.37 7.21
26 Glyceritol 15.68 2.85
27 Benzoic acid 15.9 1.30
28 Glycerol formal 16.71 0.69
29 Pyrocatechol 17.33 0.87
30 Coumaran 18.07 2.86
(table continues)
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cells and human cervical carcinoma (HeLa) cells lines, 
respectively. In addition, the same study also reported 
that the 95% ethanol extract of noni had IC
50
 higher 
than 600 µg/mL in liver cancer (HepG2) and breast 
cancer (MCF-7) cell lines (13). In comparison with the 
present study, the IC
50
 value of noni extract in breast 
cancer cells, MDA-MB-231 and liver cancer cell lines, 
HepG2 was much lower (Table I) than that obtained 
in the previous study (13) possibly due to a different 
percentage of extraction solvent and different parts of 
the plant used. 
A previous study had shown that damnacanthal and 
nordamnacanthal, compounds that extract from noni 
roots were able to induce apoptosis through intrinsic 
pathways and arrest the cell cycle in oral squamous cell 
carcinoma (OSCC) cells (25). Another study also reported 
that ethyl acetate extract of noni fruits demonstrated the 
cell cycle arrest at the G1/S phase and G0/G1 phase in 
MCF-7 and MDA-MB-231 cells, respectively (26). 
All cells-treated with noni extracts (Fig. 3 and 4) 
markedly increase the cell population of sub G0/G1 
phase indicating DNA fragmentation in apoptotic cells. 
Moreover, the proportion of cell death was significantly 
increased in a dose-dependent manner in cancer cells-
treated with noni shoot extracts. The increment of cell 
count in sub G0/G1 phase showed that cells undergo 
apoptosis and cause the cleavage of nuclear DNA 
into multiple fragments (27). These findings suggest 
that noni shoot extract only induced the apoptosis in 
MDA-MB-231. However, in HT-29 cells-treated with 
noni caused cell cycle arrest at S phase and thereby an 
inhibition of DNA replication.
The most abundant compounds in noni shoot extracts 
are acetic acid and ethriol (Table II). Acetic acid is the 
simplest carboxylic acid and it is characterized by its 
sour and pungent smell (28). The effectiveness of acetic 
acid was shown to induce apoptosis in human gastric 
cancer cell lines. Hence, it’s demonstrated that acetic 
acid has potential as an anti-cancer agent (29). Ethriol is 
the organic compound in triol group where it has three 
hydroxyl functional groups and may act as antidiabetic 
and anticancer agent (30).
CONCLUSION
It was found that noni shoot extract was cytotoxic on 
MDA-MB-231 and HT-29 cell lines. Furthermore, 
noni shoot extract had less toxic effects on 3T3 cell 
lines. This implies noni shoot extract possess potential 
anti-proliferative activities without affecting normal 
cells. Noni shoot extract induced apoptosis in MDA-
MB-231 and HT-29 cell lines. Moreover, the identified 
compounds in noni (acetic acid and ethriol) shoot 
extract that was shown in this present study can be 
further investigated for their medicinal properties 
particularly their anti-cancer effects. Noni shoot extract 
Table II: Compounds that identified in noni shoot extract using GCMS
(continued)  
Peak Compound Retention Time Area (%)
31 Glycerin monoacetate 19.04 0.80
32 Pyrazine 19.76 1.09
33 Ursolic acid 21.75 1.32
34 Fourrine 21.75 0.67
35 Trimethylene Borate 21.96 1.49
36 Butanamide 22.74 0.04
37 Isobutylglycerol 23.09 0.34
38 Ethriol 23.52 16.59
39 Phenol 24.5 0.07
40 Succinic Acid 24.51 0.05
41 m-Salicyclic acid 24.75 0.49
42 Levoglucosan 24.87 1.61
43 D-allose 25.16 0.24
44 Oxalic acid 26.07 0.08
45 Ethanone 26.2 0.05
46 Fumaric acid 26.29 0.05
47 3-Deoxy-d-mannonic acid 26.45 0.19
48 Vitamin E 26.95 0.05
49 .beta.-D-glucopyranoside 27.38 0.26
50 Cyclohexanol 27.57 5.93
51 Pentanoic acid 28.03 8.22
52 Acetin 28.05 1.92
53 Muco-Inositol 28.16 1.28
54 6-Hydroxycoumarin 28.96 2.52
55 Carbamic acid 29.11 0.05
56 myo-inositol 29.13 0.02
57 Benzoic acid 31.14 0.04
58 Ascorbic acid 31.3 2.74
59 Pentadecanoic acid 31.51 1.19
60 Hexadecanoic acid 31.59 0.13
61 Phytol 31.84 0.20
62 Linolenic acid 33.26 0.03
63 Heptadecanoic acid 34.36 0.09
64 Scopoletin 34.86 1.46
65 Hexadecanoic acid 37.03 0.78
66 Acetic acid 37.77 17.98
67 Octanoic acid 38.00 1.02
68 Squalene 38.13 0.37
69 Gamma-tocopherol 38.53 0.92
70 Heptacosane 39.99 0.05
71 Campesterol 45.19 0.04
72 Vitamin E 48.46 0.32
73 Eicosanoic acid 54.96 0.11
DISCUSSION
As shown in Table I, noni shoot extract markedly 
reduced the proliferation of all types of cancer cells and 
had markedly higher cytotoxicity effects against MDA-
MB-231 and HT-29 cell lines. Several other studies had 
reported the potential cytotoxic effect of noni in various 
cancer cell lines such as in Jurkat cell lines with IC
50
 
of 14.5 to 15.0 µg/mL (24). Another study of a various 
solvent extract of noni leaves showed cytotoxicity of 
the extract in cancer cells i.e., the ethanol extract of 
noni leaves had an IC
50
 value of 169.17 µg/mL and 
310.0 µg/mL in human epidermoid carcinoma (KB) 
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possesses anti-cancer properties in selected cancer cells 
via induction of apoptosis pathway and further research 
can provide more information about noni as one of the 
possible nutraceutical or functional food product. 
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